A new and simple method was developed to produce gelatin nanoparticles of ∼ 30–40 nm for use as carriers for drug release applications. The nanoparticles were uniform in size and well dispersed. An anticancer drug, 5‐fluorouracil, was encapsulated with an efficiency as high as 85%. The nanoparticles showed sustained release of 5‐fluorouracil, and release rates varied with amount of crosslinking in the nanoparticles.
No takes yet. Share an insight, caveat, or question.
Naidu et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: